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Modeling Insertional Mutagenesis Using Gene Length
and Expression in Murine Embryonic Stem Cells
Alex S. Nord1,2,3*, Karen Vranizan2,5, Whittemore Tingley2,4, Alexander C. Zambon2,4, Kristina Hanspers2,4, Loren G. Fong1, Yan Hu1,
Peter Bacchetti6, Thomas E. Ferrin3, Patricia C. Babbitt3, Scott W. Doniger2,7, William C. Skarnes8, Stephen G. Young1, Bruce R. Conklin2,4,9*
1 Department of Medicine, MacDonald Medical Research Laboratories, University of California at Los Angeles, California, United States of America,
2 Gladstone Institute of Cardiovascular Disease, San Francisco, California, United States of America, 3 Departments of Biopharmaceutical Sciences and
Pharmaceutical Chemistry, University of California at San Francisco, California, United States of America, 4 Department of Medicine, University of
California at San Francisco, California, United States of America, 5 Functional Genomics Laboratory, University of California at Berkeley, California,
United States of America, 6 Department of Epidemiology and Biostatistics, University of California at San Francisco, California, United States of
America, 7 Washington University School of Medicine, St. Louis, Missouri, United States of America, 8 Wellcome Trust Sanger Institute Hinxton,
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Background. High-throughput mutagenesis of the mammalian genome is a powerful means to facilitate analysis of gene
function. Gene trapping in embryonic stem cells (ESCs) is the most widely used form of insertional mutagenesis in mammals.
However, the rules governing its efficiency are not fully understood, and the effects of vector design on the likelihood of genetrapping events have not been tested on a genome-wide scale. Methodology/Principal Findings. In this study, we used
public gene-trap data to model gene-trap likelihood. Using the association of gene length and gene expression with gene-trap
likelihood, we constructed spline-based regression models that characterize which genes are susceptible and which genes are
resistant to gene-trapping techniques. We report results for three classes of gene-trap vectors, showing that both length and
expression are significant determinants of trap likelihood for all vectors. Using our models, we also quantitatively identified
hotspots of gene-trap activity, which represent loci where the high likelihood of vector insertion is controlled by factors other
than length and expression. These formalized statistical models describe a high proportion of the variance in the likelihood of
a gene being trapped by expression-dependent vectors and a lower, but still significant, proportion of the variance for vectors
that are predicted to be independent of endogenous gene expression. Conclusions/Significance. The findings of significant
expression and length effects reported here further the understanding of the determinants of vector insertion. Results from
this analysis can be applied to help identify other important determinants of this important biological phenomenon and could
assist planning of large-scale mutagenesis efforts.
Citation: Nord AS, Vranizan K, Tingley W, Zambon AC, Hanspers K, et al (2007) Modeling Insertional Mutagenesis Using Gene Length and Expression
in Murine Embryonic Stem Cells. PLoS ONE 2(7): e617. doi:10.1371/journal.pone.0000617

vectors, but the extent of the expression effect in different genetrap vectors has not been systematically quantified or compared.
Splice-acceptor (SA) gene-trap vectors depend on the integration
of a new SA sequence to interrupt the trapped gene [11,12]. When
successful, SA-trap vectors inactivate the trapped gene and result
in an antibiotic-resistance gene product that allows for selection of
the mutant cell lines. These vectors lack a promoter, so
endogenous gene expression is required to drive transcription of
the vector product. However, gene expression has not been tested
on a large scale while controlling for gene length, which is also
thought to affect trappability.
In polyadenylation (poly-A) gene-trap vectors, by contrast, the
antibiotic-resistance gene is driven by a strong promoter within the

INTRODUCTION
Complete collections of well-defined mutants have helped shed light
on the biology of model organisms, such as flies [1–3] and bacteria
[4,5]. Likewise, the development of a complete collection of mouse
mutants would enhance our ability to understand mammalian
biology [6]. Libraries of mutant mouse embryonic stem cells (ESCs)
are particularly valuable because they can be readily cryopreserved
and used to generate mutant mice. Gene trapping in ESCs is an
effective, high-throughput technique for generating insertional
mutations in the mouse genome [7]. Ultimately, however, nontargeted trapping becomes inefficient; some genes are repeatedly
trapped, and others are trapped rarely, if at all [8,9]. A better
understanding of the characteristics that determine susceptibility (or
resistance) to trapping would be useful, as it would further
understanding of vector insertion into the genome and could help
guide large-scale mouse mutagenesis efforts.
The factors that determine the ‘‘trappability’’ of individual
genes (i.e., their likelihood of being inactivated by gene trapping)
are unclear. The integration of gene-trapping vectors into
chromosomal DNA is potentially influenced by a number of
factors, including the intrinsic properties of the vector, the
expression level of the gene in mouse ESCs, chromatin structure,
DNA substrate recognition, and gene size. In addition the
existence of highly favored integration sites (hotspots) complicates
efforts to understand the factors that control trappability. [10]
Gene expression levels in ESCs are believed to positively
correlate with trapping efficiency with expression-dependent
PLoS ONE | www.plosone.org
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trapping events, as predicted by the fitted models, was plotted
against a grid of length and expression values (Figure 3).
The probability that a gene would be trapped with SA-plasmid
and SA-viral vectors increased with both gene expression and gene
length. SA vectors showed highly statistically significant (P,0.0001)
effects due to gene expression (Table 2). In comparison, the poly-A
vectors showed much weaker, albeit statistically significant, expression effects (P,0.013). The trapping efficiency of the SA-plasmid
and poly-A vectors also increased with gene size (P,0.0001). SAretroviral vectors exhibited a similar length trend (P,0.0001), but for
unknown reasons, these vectors displayed a plateau effect in the
largest genes, where trapping likelihood did not increase.
The strong effect of expression on trap likelihood is likely due to
two factors. First, this effect is an inherent property of antibiotic
selection, and differences in the expression trends of endogenous
expression-dependent vectors stem from differences between cellculture and sequencing protocols. Second, the presence of the
small expression effect in poly-A vectors, where none is expected,
suggests that gene-trap likelihood is, at some level, dependent on
transcriptional activity and chromatin structure. Previous studies
of retroviral insertion with vectors similar to gene-trap vectors
yielded contradictory results concerning the effect of geneexpression level on vector insertion [14–16]; however, retroviruses
are known to integrate preferentially into transcribed genes, likely
owing to the effects of chromatin structure [17].
Although poly-A vectors do not appear to depend substantially
on gene expression levels, their use poses additional challenges.
Poly-A vectors do not require endogenous regulation of transcription, so there is a potentially greater chance that insertion in
a ‘‘non-genic’’ locus could still confer antibiotic resistance. This
could account for the diminished proportion of poly-A gene-trap
events that can be mapped to a gene (Table 1). In addition,
preferential integration at the 39 end of genes in these vectors is
due to nonsense-mediated decay of transcripts of the antibioticresistance gene-trap products. This decay typically occurs when
the vector inserts upstream of the final intron [18]. As a result,
insertion of poly-A-trap vectors at the 39 end more frequently
yields drug-resistant colonies. This bias is worrisome because the
likelihood that a gene-trap mutation will cause a null allele
decreases as the insertion site moves towards the 39 end of a gene.
Newer poly-A trap vectors may overcome the nonsense-mediated
decay issue [18] and could be an attractive alternative to
expression-based gene-trapping vectors.
In addition to expression, we found that gene length affected
trapping likelihood for all three vectors. This finding was
somewhat surprising because certain vector types are thought to
insert primarily into the ends of genes and therefore might not be
expected to exhibit significant gene-length effects. For example,
retroviral vectors preferentially inserted at the 59 end of genes in
one study [9]. Likewise, the poly-A trap vectors included in this
study insert preferentially into the 39 ends of genes [18]. Such
preferential insertion could eliminate the effects of overall length.
In addition, the first or last introns may be the dominant
determinants of this length effect, and that total gene length might
not capture this effect. Nevertheless, we found a clear enrichment
in the trapping of long genes with all retroviral vectors.
While individual insertion-specific intron length may be of
ultimate importance to the length effect observed in this study,
measurement of intron size and identification of the intron of
insertion are less reliable due to the prominence of alternative
splicing and the difficulty of mapping specific gene-trap vector
insertion sites. Further characterization of trends affecting the
intron of insertion is necessary to better understand the genelength effect described here.

vector. The stability of the transcript for the antibiotic-resistance
gene depends on the poly-A signal from the trapped gene [13].
Because the transcription of the antibiotic-resistance gene product
does not depend on the endogenous expression of the trapped
gene, poly-A trap vectors are predicted to trap genes regardless of
whether the gene is expressed in ESCs.
The method of vector delivery to cells (retroviral vector versus
plasmid DNA) may also influence which genes are inactivated by
gene trapping. Retroviruses are predicted to insert at the 59 end of
transcriptionally active genes and may recognize specific substrates
in genomic DNA. Little is known about the insertion of plasmid
vectors. Both plasmid and retroviral methods have been used in
SA gene trapping, while poly-A approaches have exclusively used
retroviral delivery methods.
The recent release of a near-complete mouse genome, advances in
techniques for estimating the levels of gene expression in a cell, and
the availability of a public gene-trapping database (www.genetrap.
org) make it possible to globally assess the likelihood that a gene will
be inactivated by gene trapping. In this study, we used regression
techniques to model the effects of gene length and gene-expression
levels on gene trapping in different gene-trap vectors. We also sought
to define hotspots for gene-trapping events by using the regression
models to identify genes trapped more frequently than predicted by
the models. Our findings provide an improved understanding of the
factors that control vector insertion in the genome.

RESULTS AND DISCUSSION
Association of gene expression and length with
gene-trap likelihood
We sought to formally test the hypothesis that length and/or
expression influence the probability that a gene will be trapped.
We applied stringent criteria to the genes included in this analysis,
limiting the dataset to genes for which accurate genomic mapping
and curated annotation were available. Because absolute gene
expression estimates, as opposed to fold changes, were necessary
for this analysis, we employed Affymetrix Gene Chips and the
GCRMA (GeneChip Robust Multi-array Analysis) gene expression estimation method (http://www.bioconductor.org) on a representative sample of E14 mouse embryonic stem cells. GCRMA
expression estimates were validated by comparisons to RT-PCR
data in the same E14 mouse ESC line [10] (Table S1). The
correlation between GCRMA and the RT-PCR-derived expression was high (Spearman’s r = 0.67, P-value,.0001), and the
relationship between expression and gene-trap likelihood in
endogenous expression-dependent vectors is consistent with previous analysis of trap likelihood with SA-plasmid vectors [10]. This
level of quality control and validation gave us confidence that we
accurately assessed relative gene expression throughout the full
range of transcriptional activity.
For this study, we focused on three major types of gene-trap
vectors (Figure 1), for which enough genes had been trapped to
allow robust comparisons. We analyzed 16322 gene-trap cell lines
in the public database (www.genetrap.org) (Table 1). We first
constructed scatter plots of the trapping frequencies for genes
versus known gene length and our expression estimates in E14
ESCs for each vector type (Figure 2). We then used regression
modeling to test length and expression simultaneously, so that we
could assess the effects of each variable on trapping, independently
of the other. For each vector, we fit a regression model to the
number of times each gene was trapped as a function of gene
length and expression. Spline-based modeling methods were used
to accommodate potential nonlinearity in the models of trap
likelihood. The expected number of traps for each gene per million
PLoS ONE | www.plosone.org
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Figure 1. Diagram of major mechanisms of gene trapping of an endogenous gene with two exons. (A) In the SA-trap, the SA site allows trapping
when inserted into any part of the gene via plasmid or viral integration. (B) The poly-A trap relies on the poly-A (pA) of the endogenous gene because
the neomycin-resistance gene does not have a poly-A tail. Note that the poly-A trap has its own constitutive promoter (prom). Also indicated are the
splice donor (SD), splice acceptor (SA), and neomycin resistance (NeoR). The major components of each trap were excluded from this diagram to
emphasize on the essential elements needed to understand the trapping models. Detailed maps of each major vector type are referenced in the
Methods section.
doi:10.1371/journal.pone.0000617.g001

likely been confounded by ignoring effects of expression and length
that we define here. To identify loci trapped with frequencies
elevated beyond those predicted by expression and length, we
flagged genes significantly outside the model prediction space and
defined them as hotspots. We used an iterative fitting process to
identify these genes separately for each vector (hotspots listed in
Table S2).
Each vector type had a unique set of hotspots, with marked
differences based upon the method of vector delivery (plasmid or
retroviral), as shown in Table 2. Hotspot insertions were more
frequent with SA-retroviral retroviral vectors (30% of total traps)
than with SA-plasmid vectors (10% of total traps). Poly-A vectors
showed a smaller hotspot effect (21% of total traps) than other
retroviral vectors. These proportions could underestimate the
actual number of genomic hotspots, as we only considered welldefined genes.
This increased presence of hotspots in retroviral-based gene
trapping could reflect the tendency of retroviral insertional
machinery to interact with specific sites in the genome [19,22–
24]. The mechanism driving hotspots with plasmid vectors is less
well understood but might involve genomic regions with high
recombination frequencies and high rates of double-stranded
break repair [25–27]. The quantitative method of identifying

Hotspots of vector insertion

..............................................

Though well known in the field of gene-trapping [9], hotspots are
difficult to define rigorously [19]. These loci, in which vector
insertion is highly enriched, are of interest not only to the genetrap community, but also to the gene therapy [19], cancer biology
[20], and HIV fields [21]. Prior attempts to define hotspots have

Table 1. Summary of gene trap data sets
......................................................................
Vector

Data set summary
Lines

Traps

Genes

% in Genes

SA-plasmid 8410

5857

2683

69.60%

SA-viral

3033

1989

708

65.60%

Poly-A

4879

1748

998

35.80%

All IGTC

49258

29147

5788

59.20%

Lines, number of cell lines in public gene trap database; Traps, number of genetrap events mapped to a gene; Genes, total number of unique genes trapped;
% in Genes, percent of gene-trap events mapped to exon/intron regions
(including UTR) of known genes.
doi:10.1371/journal.pone.0000617.t001
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Figure 2. Trapped genes by length and expression. For each vector type, genes were plotted according to their size and level of expression in ESCs.
Genes that have been trapped are shown in red. The circle size is proportional to the number of times a gene has been trapped.
doi:10.1371/journal.pone.0000617.g002

play some role in determining trap likelihood. Further examination of genes where the number of observed traps departs from
model predictions may help identify other important mechanisms
affecting insertional mutagenesis.
Our models have other limitations relating to experimental and
modeling constraints. The restricted number of total genes for
which high-confidence annotation and ESC expression data were
available reduced our dataset size. We also were limited to using
expression measurements from a single ESC line, and different
global expression states potentially exist between the different ESC
lines used in gene trapping. These constraints may affect the
accuracy of our models, contributing to the overall noise, and
these effects may be stronger at the end of the length and
expression scales, where there are fewer data points.

hotspots used here may help future investigations to identify and
characterize cellular and genomic factors that underlie insertional
hotspots.

Summary of gene-trap likelihood models
The ability of these expression and length-dependent models to
explain trapping probabilities was quantified by the percent
reduction in deviance compared to a null model with no covariates
in the datasets after hot-spot removal, analogous to the use of Rsquared in linear regression models. The percent reduction in
deviance was greater for SA-plasmid and SA-retroviral models
(34% and 19%, respectively) than for the poly-A model (6%). For
the expression-dependent SA vectors, these models explain
a substantial proportion of the deviance. The low explanatory
ability of the poly-A vector model reflects the relatively lower effect
of expression on gene-trap likelihood, and to some extent the
smaller effect of length.
Regardless of whether a gene has been inactivated by gene
trapping in our experimental data, our models can predict the
likelihood that a gene will be trapped in a single trapping event.
These predictions serve as ‘‘trapping scores’’ for each gene. The
raw trapping scores were corrected for the effects of both hotspots
and gene-trap events that could not be mapped to a gene. The
corrected scores, reported for the 7435 well-defined genes included
in our dataset in Table S2, allow the overall trapping efficiencies of
different vectors to be compared.
To validate our model, we compared the expected number of
traps from the SA-retroviral model with the observed number of
traps in gene-trap cell lines produced by Lexicon Genetics [28].
This validation set contained 48,809 cell lines from Lexicon
Genetics that could be annotated to our gene set (data in Table
S2). The Spearman’s correlation coefficient for the comparison
was 0.429 (P,0.005). This level of concordance gives us further
confidence that gene-trap likelihood was successfully modeled.
Although these models describe a significant proportion of the
variance in trap likelihood between mouse genes, other factors
undoubtedly contribute to trap likelihood, and therefore, trapping
scores should be interpreted on a limited scope for individual
genes. For instance, the expression-based vectors used in this study
fail to trap secreted and membrane-bound proteins (data not
shown). Other genomic factors that control vector insertion,
transcription, splicing, translation and protein localization all likely
PLoS ONE | www.plosone.org

Conclusion
Our findings offer a more complete understanding of factors
governing the accessibility of genes to trapping. We report the first
formal testing of the effects of gene expression and gene length on
trapping likelihood. While the effects of expression in SA-trap
vectors is confirmatory, the detection of an expression effect in
poly-A vectors is an important finding and matches previous
reports of a role of transcriptional state in vector insertion
likelihood. The length effect reported for all vectors described in
this study is a novel finding that requires further characterization
to understand the relative importance of the underlying biology. In
addition the identification of expression and length-independent
insertional hotspots is an important result and could benefit fields
other than gene-trapping. Ideally, the empirically quantified
relationships we provide here can be generalized to all genes in
the mouse genome. Mutagenesis in mouse and human ESCs will
continue to evolve with new and more powerful techniques, and
the results from this initial analysis will hopefully aid future
mammalian gene mutagenesis efforts.

MATERIALS AND METHODS
Gene-trap data
Data for gene-trap cell lines were generated with the International
Gene Trap Consortium (IGTC) identification and annotation
pipeline [29]. Annotations were obtained by genome and
transcript-based homology searching. Publicly available gene-trap
cell lines included in the IGTC database were used for the gene4
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trap data sets, and all gene-trap cell-line sequences used in our
analysis can be found in the NCBI Genome Survey Sequence
database [30].
Because numerous gene-trap vectors were used to create the cell
lines represented by the IGTC, we chose three representative
vector groups for analysis: the plasmid pGTlxf series (SA-plasmid),
the retroviral FlEx vectors (SA-retroviral), and a combination of
poly-A trap vectors (poly-A). The SA-plasmid vectors were
produced by BayGenomics (http://baygenomics.ucsf.edu). The
SA-viral vectors are a conditional system used by the German
Gene Trap Consortium (http://www.tikus.gsf.de) [31]. Poly-A cell
lines are from the Centre for Modeling Human Disease gene-trap
project (http://www.cmhd.ca/genetrap) [13]. Poly-A vectors
designed to take advantage of nonsense-mediated decay [18] were
not included in this analysis. Exon trap vectors are similar to SAtrap vectors but depend on direct, in-frame integration into the
open-reading frame of a gene [32]; however, these vectors behave
similarly to SA vectors due to cryptic splicing [33] and were
therefore omitted from this study. Secretory vectors containing
transmembrane signal sequences [34,35] were also excluded.
Vector maps are available on each gene-trap resource website.
More information on gene-trap data is available on the IGTC
website (http://www.genetrap.org).

Gene Data
Gene length and annotation data were from mouse build 36 of the
Ensembl database [36]. Length was computed as the full
transcribed genomic region, including the UTR when present.
This analysis used a set of 7435 well-characterized genes (Table
S2) for which complete sequence data were available. Similar sets
of ‘‘sentinel genes’’ have been used in analyses of gene-trap data
[28]. For this study, this set includes known genes annotated to
a Mouse Genome Informatics (MGI) symbol and an Entrez Gene
ID and not primarily identified by Riken clones. Single-exon genes
were omitted from the model, because they lack of a splice donor
site necessary for proper function of SA and poly-A trap vectors.

Expression Data
For all gene-expression data, mouse E14 ESCs were prepared as
described [37] (http://www.baygenomics.ucsf.edu). For GeneChip
studies, we performed four biological replicates using Affymetrix 430
2.0 arrays, and RNA samples were prepared as described by the
manufacturer (Affymetrix, Sunnyvale, CA). The 430 2.0 GeneChip
contains 45,101 probe sets, including 9242 probe sets that were
unambiguously mapped to a single Ensembl identification. Only
probes marked as type ‘‘_at’’ were used for the final analysis, because
we had the highest confidence of proper hybridization in these probe
sets. All other probe sets were discarded, because the probes may
cross-hybridize to mRNA products of other genes (Affymetrix). We
selected the probe set with maximal expression when there was more
than one representing a single gene.
Expression values were calculated with GCRMA (v. 1.1.5;
http://www.bioconductor.org), a method that purports to give
good estimates of expression in the entire expression spectrum
[38]. While on/off calls and removal of genes based on a low
signal-to-noise ratio may allow elimination of some spurious
expression results, use of GCRMA and full data inclusion were
necessary to model the likelihood of trapping, especially at the
lower boundaries of expression. Expression values for a subsample
of genes from the same cell type in the same tissue-culture
conditions were confirmed in TaqMan quantitative RT-PCR
experiments [37]. Raw and normalized data for these experiments
can be accessed using GEO series accession GSE8128.

Figure 3. Models of trap likelihood for gene-trap vectors. Models of
the likelihood of trapping a gene with particular length (x-axis) and
expression (y-axis) values for each gene-trap event were created
through an iterative process, in which outliers (P,0.001) were removed
before the final model was created. Probability (z-axis) is given as events
per million traps.
doi:10.1371/journal.pone.0000617.g003
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Table 2. Hotspot Effects and Model Summary
..................................................................................................................................................
Vector

Model Summary
Modeled
Events

Hotspot Effect
Modeled
Genes

Expression
P Value

Length
P Value

Explained
Deviance

Hotspot
Genes

Traps in
Hotspots

% Total
Traps
10.42%

SA-plasmid

3513

1545

,0.0001

,0.0001

34%

26

366

SA-retroviral

1187

400

,0.0001

,0.0001

19%

18

358

30.16%

Poly-A

805

442

0.013

,0.0001

6%

9

170

21.12%

Modeled events and genes represent the number of trap events and unique trapped genes considered in the modeling process. P values for expression and length
represent likelihood ratio significance tests. Explained deviance is analogous to the percent of the variance that is explained in a linear regression model. Hotspots
reported as the number of genes that fell outside the hotspot cut-off, the number of trap events in the hotspot gene set, and as the percent of modeled traps in
hotspot genes.
doi:10.1371/journal.pone.0000617.t002

covariates) for experiment n as:

Analysis
Spline-based methods were used in multinomial regression models,
with gene length and expression as model predictors and the number
of trap events in each gene as the outcome. Knot placement for
splines was based on gene-distribution percentiles. Models were
iteratively fitted to genes remaining at each round after cumulative
removal of hotspot genes, defined as genes with an observed trapping
frequency far above the expected frequency. We identified such
genes, using a cut-off of P,0.001 and re-ran the analyses without
them. These probabilities were calculated by using the Poisson
approximation to the binomial distribution with a large number of
trials and a low probability of success and were corrected for the
estimated model overdispersion. We then re-fit the model with the
hotspots deleted, repeating the process until no additional hotspots
were identified. The level of significance 0.001 P value was selected
to be conservative in the culling of genes that did not fit the model, as
we wanted to limit the number of genes removed to only those that
far exceeded predicted trap likelihood. P values for the length and
expression effects in the final models are reported, and deviance that
can be explained for each model was computed.
Trapping scores were computed directly from the fitted model as
the predicted probability of trapping, and corrected by multiplying
the proportion of events that trapped a modeled gene rather than
a hotspot or gene-trap event that could not be mapped to a gene.
Statistical analysis was performed with SAS (SAS Institute, Cary,
NC) and the R statistical environment (http://www.r-project.org).

ln ~f (xj )  logf

l~

X
n

ln ~

X

hi f (xi )Nlogf

i

X

exp½f (xi )g:

ð3Þ

i

For any given parametric form for the function f, we can
estimate the parameters by finding those that maximize this loglikelihood, with the general optimization features of the
NLMIXED procedure in SAS. For both covariates (gene length
and expression), we applied logarithmic transformations and then
used cubic parametric splines [39], choosing among models with
different degrees of freedom with the Akaike information criterion
[40] adjusted for overdispersion [41]. We assumed that the effects
of these two covariates were additive, f(xi) = f1(xi1)+f2(xi2). Adding
interaction terms did not substantially improve fits to the data.
To calculate a fitted probability of trapping for each gene, we
used equation (1) with the best-fitting parameters for f1 and f2

SUPPORTING INFORMATION
Table S1 Compares the expression as measured using RT-PCR
with expression estimates derived using GCRMA methods.
Found at: doi:10.1371/journal.pone.0000617.s001 (0.03 MB XLS)
Table S2 Summarizes the dataset used for this analysis. Included

are the length and expression values for genes included in the
analysis, number of traps in each gene by gene-trap vector, and the
derived trap score for each gene. Hotspots genes are tagged in the
trap score column for each vector. Omniback gene-trap events, used
here as a validation set, are listed in the final column.
Found at: doi:10.1371/journal.pone.0000617.s002 (1.60 MB XLS)
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ð1Þ

i

where the sum in the denominator is over all genes that might be
trapped, f is a function of the covariates, and xi is the vector of
covariates for gene i. For example, a simple linear model with two
covariates would be f(xi) = b1xi1+b2xi2. Here we restrict attention to
genes whose length and expression are known and to the
experiments where one of these genes was trapped. Letting j
denote the gene trapped in the nth experiment, we can write the
log-likelihood (up to a constant that does not depend on the
PLoS ONE | www.plosone.org

ð2Þ

Letting hi denote the number of times gene i was trapped, we can
then write the log-likelihood for the entire set of experiments as:

Because each experiment (trap event) selects one of a known set of
genes that could be trapped, the data fit the statistical framework
of multinomial regression. Let n = 1 to N index experiments that
trapped a gene. For each experiment, we assumed that the
probability that gene j is the one that is trapped is a function of
covariates. Let x be the matrix with a row for each gene and
a column for each covariate. A multinomial model for which gene
is trapped in each experiment is then defined by:
X

exp½f (xi )g

i

Model Specification

Pfj trappedjxg~exp½f (xj )=f

X
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